Finance

Beta
Lists
BTSG:NASDAQ
Brightspring Health Services Inc
$57.40
0.00%
(0.00) 1D
$57.22
-0.31% (-0.18)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BTSG...
Open
$57.20
High
$58.58
Low
$56.20
Mkt. cap
11.32B
Avg. vol.
3.12M
Volume
8.01M
P/E ratio
40.90
52-wk high
$62.10
52-wk low
$19.01
EPS
$1.40
Shares outstanding
193.92M
No. of employees
24K
Open
$57.20
High
$58.58
Low
$56.20
Mkt. cap
11.32B
Avg. vol.
3.12M
Volume
8.01M
P/E ratio
40.90
52-wk high
$62.10
52-wk low
$19.01
EPS
$1.40
Shares outstanding
193.92M
No. of employees
24K
Analyst outlook
Analyst Ratings
Based on 13 analysts giving stock ratings to BTSG in the past 3 months
Strong Buy
Buy
13
Hold
0
Sell
0
12 month forecast
Based on 13 Wall Street analysts offering 12 month price targets for BTSG in the last 3 months.
Highest
Current $57.40
$71.00 (+23.69%)
Average
$62.92 (+9.62%)
Lowest
$55.00 (-4.18%)
News stories
From sources across the web
About Brightspring Health Services Inc
CEOJon B. Rousseau
Employees23.5K
Founded1974
HeadquartersLouisville, Kentucky, United States
SectorHealth care provider
Websitebrightspringhealth.com
Last report
May 1, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.39 / $0.31
+26.06%beat
Revenue / Est. (USD)
3.61B / 3.39B
+6.55%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.15B
3.33B
3.55B
3.61B
Cost of goods sold
2.77B
2.94B
3.14B
3.13B
Cost of revenue
2.77B
2.94B
3.14B
3.13B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
326.30M
304.16M
304.44M
360.77M
Operating expense
326.30M
304.16M
304.44M
360.77M
Total operating expenses
3.10B
3.25B
3.44B
3.49B
Operating income
48.56M
87.84M
108.11M
121.45M
Other non operating income
-
-
-
-
EBT including unusual items
9.78M
49.61M
69.58M
82.83M
EBT excluding unusual items
9.78M
49.61M
69.58M
82.83M
Income tax expense
1.24M
12.12M
20.03M
8.55M
Effective tax rate
12.66%
24.43%
28.78%
10.32%
Other operating expenses
-
-
-
-
Net income
28.21M
55.84M
77.08M
148.77M
Net profit margin
0.90%
1.67%
2.17%
4.12%
Earnings per share
0.22
0.30
0.33
0.39
Interest and investment income
-
-
-
-
Interest expense
-38.78M
-38.24M
-38.54M
-38.62M
Net interest expenses
-38.78M
-38.24M
-38.54M
-38.62M
Depreciation and amortization charges
-
-
-
-
EBITDA
90.40M
128.60M
147.64M
160.54M
Gain or loss from assets sale
1.45M
342.00K
573.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer